US2004076632A1PendingUtilityA1

DNA vaccine against feline immunodeficiency virus

Priority: Jun 14, 1999Filed: Sep 26, 2003Published: Apr 22, 2004

Est. expiryJun 14, 2019(expired)· nominal 20-yr term from priority

Inventors:Ruitang Deng Mark Roth Michael Shepperd David W. Wheeler Terecita Yule Eric Fuog Suresh Jeevarathnam Anthony Johnson William Koertje

A61K 2039/54A61K 39/21A61K 2039/552A61K 2039/525A61K 2039/545A61K 39/12A61P 31/12C12N 2740/15034A61P 31/14A61K 2039/53

PatentIndex Score

Cited by

References

Claims

Abstract

The present invention is directed to vaccine compositions that can be used to protect cats against feline immunodeficiency virus. More particularly, the present invention relates to polynucleotide molecules that can be used as vaccine components against feline immunodeficiency virus.

Claims

exact text as granted — not AI-modified

What is claimed is:  
     
         1 . An isolated antibody that binds specifically to an FIV protein.

Join the waitlist — get patent alerts

Track US2004076632A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.